2005
DOI: 10.1016/j.jpain.2005.01.196
|View full text |Cite
|
Sign up to set email alerts
|

Determination of the optimal configuration of ALGRX 3268 for induction of local analgesia prior to venipuncture in the antecubital fossa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2008
2008
2015
2015

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…94 The significant analgesic effects of the LHM powder intradermal injection system have been demonstrated in pediatric populations undergoing venipuncture (Table 5). [95][96][97] In 1 randomized double-blind study, 307 children aged 3 to 18 years were randomly assigned to receive a predecessor system similar to the currently approved device or matching sham placebo at the back of the hand 2 to 3 minutes before venipuncture. 97 Subjects who received the active system exhibited mean pain reductions (effect sizes) of 33% to 46% relative to sham placebo.…”
Section: Laser-assisted Local Anesthetic Deliverymentioning
confidence: 99%
“…94 The significant analgesic effects of the LHM powder intradermal injection system have been demonstrated in pediatric populations undergoing venipuncture (Table 5). [95][96][97] In 1 randomized double-blind study, 307 children aged 3 to 18 years were randomly assigned to receive a predecessor system similar to the currently approved device or matching sham placebo at the back of the hand 2 to 3 minutes before venipuncture. 97 Subjects who received the active system exhibited mean pain reductions (effect sizes) of 33% to 46% relative to sham placebo.…”
Section: Laser-assisted Local Anesthetic Deliverymentioning
confidence: 99%
“…Previous studies of similar delivery systems in adults and children showed onset of cutaneous analgesia within 1 to 3 minutes, reducing procedural pain. [17][18][19][20][21] In addition, an earlier randomized, doubleblind, placebo-controlled Phase III trial of this device in 579 children aged 3 to 18 years confirmed the 1-to 3-minute onset of action and a significant reduction in subsequent pain scores for venous cannulation or venipuncture in the back of the hand or the antecubital fossa. 22 The present, similarly designed study seeks to confirm the safety, efficacy, and tolerability of this delivery system.…”
Section: Introductionmentioning
confidence: 99%